Frequently Asked Questions
The market is segmented based on Asia-Pacific Prebiotics for Infant Formula Market, By Type (Human Milk Oligosaccharides (HMOS), Galactooligosaccharides (GOS), Fructooligosaccharides (FOS), Mannan-Oligosaccharides (MOS), Polydextrose (PDX), Lactulose (LOS), Inulin), Source (Bacteria, Algae, Fungi, Plants & Vegetables), Grade (Inorganic, Organic), Form (Powder, Liquid), Product Type (Standard Formula, Toddler Formula, Follow Up Formula, Special Formula), Infant Age (0-6 Months, 6-12 Months, 1-3 Years) – Industry Trends and Forecast to 2031.
.
The Asia Pacific Prebiotics For Infant Formula Market size was valued at USD 436.48 USD Million in 2023.
The Asia Pacific Prebiotics For Infant Formula Market is projected to grow at a CAGR of 7.1% during the forecast period of 2024 to 2031.
The major players operating in the market include Jennewein Biotechnologie GmbH, zuChem Inc., Biosynth Carbosynth, ELICITYL SA, Dextra Laboratories Limited, Glycom A/S, Tereos, Ingredion Incorporated, Royal FrieslandCampina N.V., Südzucker AG, Cargill, Incorporated., Fonterra Co-operative Group, Royal Cosun, COSUCRA, New Francisco (Yunfu City) Biotechnology Corporation Limited, Dana Dairy Group, Glycosyn LLC, DUPONT.
The market report covers data from the China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, and Rest of Asia-Pacific..
